Levocetirizine Dihydrochloride Tablet
Product Images NDC 50090-1430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 50090-1430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber1 (Camber1)

FDA Label Image

Label Image (Lbl500901430)

Label Image (Lbl500901430)
Label of Levocetirizine Dihydrochloride 5 mg oral tablets by A-S Medication Solutions. The facsimile coated tablet packaging contains 30 tablets and instructs storage at 60 to 70 degrees Fahrenheit. The label displays the product NDC 50090-1430 and batch or lot number 6501-0.*
FDA Label Image

Levocitirizinestructure (Levocitirizinestructure)

Levocitirizinestructure (Levocitirizinestructure)
Chemical structure of Levocetirizine Dihydrochloride shown as a skeletal formula with chlorine-substituted phenyl rings, a piperazine ring, and carboxyl group with dihydrochloride indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.